L26/P-891 Cost-effectiveness of natural, modified natural and artificial endometrial preparation strategies for frozen embryo transfer in ovulatory women: a secondary analysis of an RCT
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von T. Pham Duong und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Are natural cycle (NC) or modified natural cycle (mNC) transfer strategies more cost-effective than artificial cycle (AC) strategy for frozen embryo transfer in ovulatory women? Summary answer NC transfer strategy is cost-effective compared with AC strategy with comparable effectiveness but lower costs; mNC strategy is less cost-effective than AC. What is known already Frozen embryo transfer (FET) is increasingly used in assisted reproductive technology. Different endometrial preparation strategies have been compared for clinical effectiveness, but cost-effectiveness data are limited. Natural and modified natural cycles avoid exogenous hormones but may have higher cancellation rates. Artificial cycles require hormone administration and offer better cycle completion rates. Economic evaluation integrating both clinical outcomes and healthcare costs is essential for informed decision-making in clinical practice and resource allocation in fertility treatment. Study design, size, duration A cost-effectiveness analysis (CEA) was performed alongside a randomised controlled trial (RCT) comparing three endometrial preparation strategies (NC, mNC, and AC) for FET in 1,428 ovulatory women (476 per group). The study was conducted between March 2021 and March 2023 at a single fertility centre. The effectiveness measure was the live birth rate after one FET cycle. Direct medical costs were calculated from first endometrial preparation through live birth using a micro-costing approach. Participants/materials, setting, methods Ovulatory women aged 18–45 years undergoing FET were included. NC used no exogenous hormones; mNC used hCG for ovulation triggering; and AC used oestradiol and progesterone. Cancelled NC or mNC cycles underwent repeat endometrial preparation with AC. Cost-effectiveness was assessed from a patient perspective using direct medical costs covering embryo transfer procedures for both initial and subsequent cycles. ICERs for NC and mNC versus AC were estimated using probabilistic sensitivity analysis and cost-effectiveness acceptability curves Main results and the role of chance Between March 2021 and March 2023, 1,428 women were randomised (476 per group). Ninety-nine first FET cycles were cancelled in both the NC and mNC groups, compared with none in the AC group. Cancelled NC and mNC cycles subsequently underwent repeat endometrial preparation with AC before embryo transfer. The live birth rate after one FET was 36.6% in the NC group, 33.4% in the mNC group, and 34.0% in the AC group (relative risk [95% confidence interval] for NC vs AC: 1.07 [0.87–1.33]; for mNC vs AC: 0.98 [0.79–1.22]). Mean costs per patient were €1,567 for NC, €1,555 for mNC, and €1,942 for AC. Costs per live birth were €4,263, €4,655, and €5,707, respectively. Compared with AC, NC was less costly with an ICER of −€13,725 per 1% additional live birth (95% CI −€103,950 to €110,497), while mNC showed no cost-effectiveness advantage. Probabilistic sensitivity analyses demonstrated wide uncertainty around ICER estimates, reflecting small effectiveness differences. Cost-effectiveness acceptability curves indicated a high probability of NC being cost-effective compared with AC at willingness-to-pay thresholds below €20,000 per 1% additional live birth. Limitations, reasons for caution The analysis was limited to direct medical costs, excluding indirect costs and patient preferences. Effectiveness differences were not statistically significant. As a single-centre study conducted in Vietnam, generalisability may be limited, and unit costs may not reflect other settings Wider implications of the findings NC transfer strategy offers cost savings compared with AC strategy with comparable clinical effectiveness. mNC strategy offers cost savings but with lower effectiveness. These findings suggest that NC strategy should be considered a cost-effective alternative for ovulatory women with regular menstrual cycles, potentially reducing treatment costs without compromising reproductive outcomes. Trial registration number Yes
Zitieren
APA
Duong, T. P., NA, V. H., HN, M. N., Huynh, B., M, T. H., Wang, R., & N, L. V. (2026). L26/P-891 Cost-effectiveness of natural, modified natural and artificial endometrial preparation strategies for frozen embryo transfer in ovulatory women: a secondary analysis of an RCT. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1215
Vancouver
Duong TP, NA VH, HN MN, Huynh B, M TH, Wang R, et al. L26/P-891 Cost-effectiveness of natural, modified natural and artificial endometrial preparation strategies for frozen embryo transfer in ovulatory women: a secondary analysis of an RCT. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1215
BibTeX
@article{Duong2026,
author = {Duong, T. Pham and NA, V. Ho and HN, M. Nguyen and Huynh, B.G. and M, T. Ho and Wang, R. and N, L. Vuong},
title = {L26/P-891 Cost-effectiveness of natural, modified natural and artificial endometrial preparation strategies for frozen embryo transfer in ovulatory women: a secondary analysis of an RCT},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1215}
}
EUVIMED